NCT01582165View on ClinicalTrials.gov

Women With Chest Pain and no Significant Coronary Artery Stenosis; A Study on Microvascular Resistance

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Angina Pectoris
Interventions
DRUG

Rosuvastatin

Rosuvastatin 20 mg once daily vs placebo for 6 months

DRUG

Placebo.

Placebo once daily vs rosuvastatin for 6 months

Trial Locations (1)

0380

Oslo University Hospital, Dep of Cardiology, Rikshospitalet, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT01582165 - Women With Chest Pain and no Significant Coronary Artery Stenosis; A Study on Microvascular Resistance | Biotech Hunter | Biotech Hunter